McKesson MCK · USD
Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States
S&P 500
1,059.37
-0.14%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About McKesson
From its filings with the US Securities and Exchange Commission
McKesson is based in Irving, Texas and is incorporated in Delaware. Its shares trade on NYSE under the ticker MCK. It is a member of the S&P 500. The SEC classifies its business as wholesale-drugs, proprietaries & druggists' sundries. In the fiscal year to 31 March 2026, it reported revenue of $403.43bn and net income of $4.76bn. At that date it held total assets of $82.32bn and shareholders' equity of −$2.17bn.
McKesson Corporation together with its subsidiaries (collectively, the “Company,” “McKesson,” “we,” “our,” or “us” and other similar pronouns), which traces its business roots to 1833, is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable.
Commencing in the second quarter of fiscal 2026, we implemented a new segment reporting structure which resulted in four reportable segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. Our former Norwegian operations were included in Other. All prior segment information has been recast to reflect the Company’s new segment structure and current period presentation.
Our North American Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter (“OTC”) pharmaceutical drugs, and other healthcare-related products to customers in the United States (“U.S.”) and Canada. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate sites) and provides consulting, outsourcing, technological, and other services. The U.S. distribution operations were previously included in the former U.S.
Quoted from its 10-K, filed 8 May 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 10 Nov 1994
- Employees
- 43,000
- Website
- mckesson.com ↗
- Head office
- 6555 STATE HIGHWAY 161, IRVING, TX, 75039
- Incorporated in
- DE
- Classification
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Donald KnaussIndependent Chairman of the Board$593,991
- Mr. Brian TylerChief Executive Officer, Director, since 2012$20.2m
- Mr. Britt VitaloneChief Financial Officer, Executive Vice President$7.7m
- Ms. Leann SmithChief Human Resources Officer, Executive Vice President$3.7m
- Ms. Michele LauExecutive Vice President, Chief Legal Officer$5.2m
- Mr. Thomas RodgersExecutive Vice President, Chief Strategy and Business Development Officer$3.2m
- Mr. Dominic CarusoIndependent Director$358,672
- Ms. Lynne DoughtieIndependent Director$123,841
- Mr. W. Roy DunbarIndependent Director$333,672
- Dr. Deborah DunsireIndependent Director$345,963
- Dr. Julie GerberdingIndependent Director$123,841
- Mr. James HintonIndependent Director$333,672
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 67
- Environment
- 53
- Social
- 61
- Governance
- 86
- Direct emissions (scope 1)
- 79,848 t
- Energy emissions (scope 2)
- 153,783 t
- Value chain emissions (scope 3)
- 32,569,160 t
- Women in the workforce
- 62%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Mckesson Corp holds a prominent position in the healthcare industry, making it a key player in the market.
- The company benefits from a well-established and efficient distribution network, ensuring timely delivery of products and services.
- Mckesson Corp offers a wide range of healthcare solutions and services, catering to various needs and requirements.
Weaknesses
- A significant portion of Mckesson Corp's revenue is derived from a few key customers, increasing vulnerability to their actions and demands.
- As a healthcare company, Mckesson Corp is subject to stringent regulations and compliance requirements, which may pose operational challenges.
- The company needs to continually focus on cost management strategies to maintain profitability in the highly competitive market.
Opportunities
- The healthcare industry is expected to experience significant growth in the coming years, presenting opportunities for Mckesson Corp to expand its market reach.
- Leveraging technology and embracing digital transformation can enhance efficiency, improve patient outcomes, and provide new avenues for revenue generation.
- Exploring international markets can help Mckesson Corp tap into new customer bases and diversify its revenue streams.
Threats
- The healthcare industry is highly competitive, with numerous players vying for market share, potentially impacting Mckesson Corp's growth prospects.
- Fluctuations in government policies and economic conditions can create uncertainty and impact the overall healthcare market and Mckesson Corp's operations.
- As a custodian of sensitive patient data, Mckesson Corp faces the constant threat of data breaches, necessitating robust security measures.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.